{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:44:32Z","timestamp":1766159072132,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI133561"],"award-info":[{"award-number":["U01AI133561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL068835"],"award-info":[{"award-number":["HL068835"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jtha.2022.11.034","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:11:32Z","timestamp":1674108692000},"page":"639-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Platelet tissue factor pathway inhibitor-\u03b1 dampens cardiac thrombosis and associated fibrosis in mice"],"prefix":"10.1016","volume":"21","author":[{"given":"Susan A.","family":"Maroney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas D.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Lincoln","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan E.","family":"Mast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.11.034_bib1","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/jth.14995","article-title":"Platelet anticoagulant proteins: modulators of thrombosis propensity within a procoagulant cell","volume":"18","author":"Siebert","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V69.2.645.645","article-title":"Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation","volume":"69","author":"Rao","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib3","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2022.11.034_bib4","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2022.11.034_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/jth.13665","article-title":"Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitoralpha, and protein S","volume":"15","author":"Dahlback","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jth.15690","article-title":"A\u00a0hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIalpha-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIalpha, and protein S","volume":"20","author":"Dahlback","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jth.15547","article-title":"The preAR2 region (1458-1492) in factor V-Short is crucial for the synergistic TFPIalpha-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIalpha","volume":"20","author":"Dahlback","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib8","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1016\/S0021-9258(19)70660-7","article-title":"Regulation of activated protein C by a new protein. A possible function for bovine protein S","volume":"255","author":"Walker","year":"1980","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2022.11.034_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0092-8674(80)90112-9","article-title":"Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells","volume":"21","author":"Baker","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2022.11.034_bib10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/ATVBAHA.110.220293","article-title":"Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth","volume":"31","author":"Maroney","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2022.11.034_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood-2009-04-217240","article-title":"Anticoagulant and antithrombotic properties of platelet protease nexin-1","volume":"115","author":"Boulaftali","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib12","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.2019003630","article-title":"Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus","volume":"135","author":"Calzavarini","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1538-7836.2008.03033.x","article-title":"Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans","volume":"6","author":"Maroney","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2022.11.034_bib15","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1538-7836.2009.03454.x","article-title":"Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice","volume":"7","author":"Maroney","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib16","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1111\/jth.14288","article-title":"Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology","volume":"16","author":"Girard","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.11.034_bib18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V78.2.394.394","article-title":"Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.120.315728","article-title":"Major reservoir for heparin-releasable TFPIalpha (tissue factor pathway inhibitor alpha) is extracellular matrix","volume":"41","author":"Peterson","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2022.11.034_bib20","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2006-07-037283","article-title":"Active tissue factor pathway inhibitor is expressed on the surface of coated platelets","volume":"109","author":"Maroney","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib21","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jth.15697","article-title":"Regulation of coagulation by tissue factor pathway inhibitor: implications for hemophilia therapy","volume":"20","author":"Mast","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib22","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIalpha","volume":"123","author":"Vincent","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2022.11.034_bib23","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2014-08-592733","article-title":"A\u00a0novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function","volume":"125","author":"Cunha","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib24","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/jth.15314","article-title":"F5-Atlanta: a novel mutation in F5 associated with enhanced East Texas splicing and FV-short production","volume":"19","author":"Zimowski","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jth.15612","article-title":"Factor V east Texas variant causes bleeding in a three-generation family","volume":"20","author":"Peterson","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029964","article-title":"Simukunin from the salivary glands of the black fly Simulium vittatum inhibits enzymes that regulate clotting and inflammatory responses","volume":"7","author":"Tsujimoto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2022.11.034_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V90.3.944","article-title":"Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib28","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood-2015-03-633958","article-title":"A\u00a0balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development","volume":"125","author":"Ellery","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib29","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/jth.15430","article-title":"The contribution of TFPIalpha to the hemostatic response to injury in mice","volume":"19","author":"Marar","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib30","first-page":"32","article-title":"Smooth muscle alpha-actin expression in mitral valve interstitial cells is important for mediating extracellular matrix remodeling","volume":"7","author":"Dye","year":"2020","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.jtha.2022.11.034_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2019.01.038","article-title":"Cardio-oncology\u2014strategies for management of cancer-therapy related cardiovascular disease","volume":"280","author":"Totzeck","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2022.11.034_bib32","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer","volume":"73","author":"Atkins","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2022.11.034_bib33","doi-asserted-by":"crossref","first-page":"H392","DOI":"10.1152\/ajpheart.00124.2017","article-title":"Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction","volume":"313","author":"Saiki","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jtha.2022.11.034_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacbts.2018.01.014","article-title":"Radiation-induced endothelial vascular injury: a review of possible mechanisms","volume":"3","author":"Venkatesulu","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jtha.2022.11.034_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcvm.2020.00041","article-title":"Cardiovascular damage associated with chest irradiation","volume":"7","author":"Mrotzek","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2022.11.034_bib36","first-page":"28","article-title":"Cardiac fibroblast to myofibroblast phenotype conversion\u2014an unexploited therapeutic target","volume":"6","author":"Czubryt","year":"2019","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.jtha.2022.11.034_bib37","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2022.11.034_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jtha.2022.11.034_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","article-title":"Cardiac fibroblast diversity","volume":"82","author":"Tallquist","year":"2020","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jtha.2022.11.034_bib40","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jtha.2022.11.034_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43882","article-title":"Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury","volume":"8","author":"Farbehi","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jtha.2022.11.034_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/656481","article-title":"S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond","volume":"2010","author":"Sorci","year":"2010","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"10.1016\/j.jtha.2022.11.034_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4331\/wjbc.v4.i1.1","article-title":"S100B protein in tissue development, repair and regeneration","volume":"4","author":"Sorci","year":"2013","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.jtha.2022.11.034_bib44","article-title":"Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbalpha","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2022.11.034_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.ircmb.2022.04.005","article-title":"Macrophages in the heart: active players or simple bystanders?","volume":"368","author":"Bozzi","year":"2022","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.jtha.2022.11.034_bib46","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.2019001530","article-title":"Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis","volume":"134","author":"Muller-Calleja","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejcb.2010.12.002","article-title":"Molecular pathways of platelet factor 4\/CXCL4 signaling","volume":"90","author":"Kasper","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.jtha.2022.11.034_bib48","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood.V72.6.2020.2020","article-title":"Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor","volume":"72","author":"Novotny","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib49","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1253\/circj.CJ-16-1003","article-title":"Defining the cardiac fibroblast","volume":"80","author":"Ivey","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jtha.2022.11.034_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/wrr.12947","article-title":"Novel factors that activate and deactivate cardiac fibroblasts: a new perspective for treatment of cardiac fibrosis","volume":"29","author":"de Oliveira Camargo","year":"2021","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jtha.2022.11.034_bib51","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1016\/S0021-9258(18)32345-7","article-title":"Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization","volume":"258","author":"Assoian","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2022.11.034_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108594","article-title":"TGF beta-1, -2 and -3 in the modulation of fibrosis in the cornea and other organs","volume":"207","author":"Wilson","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtha.2022.11.034_bib53","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nm0995-932","article-title":"Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin","volume":"1","author":"Grainger","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2022.11.034_bib54","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.3390\/ijms22094492","article-title":"Blood platelets as an important but underrated circulating source of TGFbeta","volume":"22","author":"Karolczak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2022.11.034_bib55","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1111\/jth.15066","article-title":"Platelet polyphosphate induces fibroblast chemotaxis and myofibroblast differentiation","volume":"18","author":"Suess","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110189","article-title":"CXCL4 drives fibrosis by promoting several key cellular and molecular processes","volume":"38","author":"Affandi","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtha.2022.11.034_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehw119","article-title":"Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation","volume":"38","author":"Spronk","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2022.11.034_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jtha.2022.11.034_bib59","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1172\/JCI3077","article-title":"Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice","volume":"102","author":"Tsoporis","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2022.11.034_bib60","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2022.11.034_bib61","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCRESAHA.120.316903","article-title":"Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas","volume":"127","author":"Zernecke","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2022.11.034_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2014.05.009","article-title":"Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice","volume":"408","author":"Abram","year":"2014","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jtha.2022.11.034_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54590","article-title":"A\u00a0new genetic strategy for targeting microglia in development and disease","volume":"9","author":"McKinsey","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jtha.2022.11.034_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.08.021","article-title":"CXCL4-induced macrophages in human atherosclerosis","volume":"122","author":"Domschke","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.jtha.2022.11.034_bib65","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood-2018-09-877787","article-title":"The Gp1ba-Cre transgenic mouse: a new model to delineate platelet and leukocyte functions","volume":"133","author":"Nagy","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/jth.12784","article-title":"Broader expression of the mouse platelet factor 4-cre transgene beyond the megakaryocyte lineage","volume":"13","author":"Pertuy","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107057","article-title":"A\u00a0novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin","volume":"109","author":"Carrington","year":"2021","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"key":"10.1016\/j.jtha.2022.11.034_bib68","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/bloodadvances.2017010868","article-title":"Platelet TGF-beta1 deficiency decreases liver fibrosis in a mouse model of liver injury","volume":"2","author":"Ghafoory","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.11.034_bib69","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2011-09-377648","article-title":"Platelet TGF-beta1 contributions to plasma TGF-beta1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload","volume":"119","author":"Meyer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.034_bib70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/jth.15134","article-title":"The role of platelets in thrombus fibrosis and vessel wall remodeling after venous thrombosis","volume":"19","author":"DeRoo","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.034_bib71","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2017.09.016","article-title":"Direct\u00a0thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice","volume":"159","author":"Dong","year":"2017","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622076504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622076504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:38:35Z","timestamp":1761536315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622076504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1538783622076504"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.11.034","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet tissue factor pathway inhibitor-\u03b1 dampens cardiac thrombosis and associated fibrosis in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}